Trademark applications and grants for Transgene S A. Transgene S A has 10 trademark applications. The latest application filed is for "INVIR IO"
Patent Application | Date |
---|---|
M2-DEFECTIVE POXVIRUS 20220056481 - 17/418426 KLEINPETER; Patricia ;   et al. | 2022-02-24 |
NOVEL ANTIBODIES AND NUCLEOTIDE SEQUENCES, AND USES THEREOF 20220041723 - 17/272740 FRENDEUS; Bjorn ;   et al. | 2022-02-10 |
COMBINATION OF ONCOLYTIC VIRUS WITH IMMUNE CHECKPOINT MODULATORS 20200376052 - 16/985607 Zitvogel; Laurence ;   et al. | 2020-12-03 |
ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS 20200197457 - 16/725485 Silvestre; Nathalie ;   et al. | 2020-06-25 |
ONCOLYTIC VIRUSES AND THERAPEUTIC MOLECULES 20190330655 - 16/474312 ERBS; Philippe ;   et al. | 2019-10-31 |
SEC | 0001056910 | TRANSGENE SA |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.